2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 20:09, 16 November 2023
, 16 November 2023→Potential Benefits
| Line 107: | Line 107: | ||
{| class="wikitable" style="width:90%; background-color:white; vertical-align:top; margin:auto;" | {| class="wikitable" style="width:90%; background-color:white; vertical-align:top; margin:auto;" | ||
|+ | |+ | ||
! colspan="2" |Potential health benefits in mouse models | |||
! colspan="2" |Results of published human clinical trials | |||
|- | |||
| style="border:none;" | [[File:NMN NAD+ Mice.png|frameless|100px]] | | style="border:none;" | [[File:NMN NAD+ Mice.png|frameless|100px]] | ||
| style="border-left: none;" | | | style="border-left: none;" | | ||